Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Givinostat in Becker Muscular Dystrophy
NCT03238235Phase 2Completed
- Sponsor
- Italfarmaco
- Start
- Jan 2018
- Primary completion
- Mar 2021
- Countries
- 2
01
Overview
A Phase 2 trial of givinostat in Becker muscular dystrophy (BMD), sponsored by Italfarmaco. Started Jan 2018; status: completed.
02
Drugs
givinostat
03
Conditions
Becker muscular dystrophy (BMD)
Beyond the preview
Go deeper on NCT03238235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03238235.